Supporting the

Neuroendocrine Cancer Community

From Patent to Patient

Jan 22, 2019

Analysing access to innovative cancer drugs. 

The Institute of Cancer Research (ICR) have produced a report which asks how we can best harness advances in science to bring innovative drugs to patients. It is designed to help reshape the landscape for drug discovery and development – and create tomorrow’s cancer treatments.

Click here to read the full report.